Cargando…
A Coronavirus Disease 2019 (COVID-19) Mystery: Persistent Fevers and Leukocytosis in a Patient With Severe COVID-19
Short-course glucocorticosteroids are being used and tocilizumab (TCZ) had been used to treat patients with severe coronavirus disease 2019 (COVID-19) disease. These agents, when administered individually, have been associated with tuberculosis (TB) during chronic use. We report a case of TB in a 44...
Autores principales: | Sasson, Arielle, Aijaz, Amna, Chernyavsky, Svetlana, Salomon, Nadim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747365/ https://www.ncbi.nlm.nih.gov/pubmed/33365357 http://dx.doi.org/10.1093/ofid/ofaa558 |
Ejemplares similares
-
PULMONARY CAVITARY TB IN A PATIENT WITH SARS COV 2 PNEUMONIA
por: Sasson, Arielle, et al.
Publicado: (2020) -
Acute Immune Thrombocytopenia (ITP) Following COVID-19 Vaccination in a Patient With Previously Stable ITP
por: Jawed, Muzamil, et al.
Publicado: (2021) -
Opportunistic Fungal Infection Associated With
COVID-19
por: Cafardi, John, et al.
Publicado: (2021) -
All That Coughs Is Not COVID-19: A Delayed Diagnosis of Disseminated Coccidioidomycosis Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Chen, Joshua C, et al.
Publicado: (2021) -
Pancytopenia and Profound Neutropenia as a Sequela of Severe SARS-CoV-2 Infection (COVID-19) With Concern for Bone Marrow Involvement
por: Hernandez, Jarelys M, et al.
Publicado: (2021)